Views: 500 Author: Site Editor Publish Time: 2026-10-29 Origin: Site
No — Ceylon cinnamon and cassia cinnamon are not the same plant, and for a supplement buyer the difference that matters most is documentation, not flavor.
Both come from the dried bark of trees in the Cinnamomum genus, and both are sold under the same one-word name. Ceylon cinnamon (Cinnamomum verum, also written Cinnamomum zeylanicum) is known as "true cinnamon" and grows primarily in Sri Lanka. Cassia cinnamon (Cinnamomum aromaticum, also written Cinnamomum cassia) is grown in southeastern Asia and is the most common type sold in North America, according to the NIH National Center for Complementary and Integrative Health (NCCIH). On coumarin, the categories differ at the category level: the German Federal Institute for Risk Assessment (BfR) states that coumarin occurs in relatively high concentrations in cassia-type cinnamon, while Ceylon contains low levels; NCCIH notes that Ceylon may contain a trace amount.
For a brand or sourcing team, that background converts into three practical questions:
1. Is the species fixed in the ingredient specification — not just in the marketing name?
2. Is the coumarin position supported by batch evidence, or only by the species name?
3. Can the supplier document identity, traceability, and batch-level quality the way your destination market expects?
This article works through each: the botanical background, the coumarin question, the specifications and documents worth comparing, and how to turn the comparison into a product brief. Note on scope: the regulatory references below describe the United States dietary supplement framework; requirements in the EU and other markets differ and should be checked separately.
Cinnamon is the dried bark of Cinnamomum trees, and the two commercial categories overlap in name and everyday use while remaining botanically distinct. NCCIH notes that the types and parts of cinnamon have important differences in chemical composition, and that these differences can affect a product's impact on people.
Two facts make this a purchasing issue rather than a trivia point:
Products do not always state the species or the plant part. NCCIH flags this directly: cinnamon products may not clearly indicate which species (for example, Ceylon or cassia) or which parts (bark, leaves, roots) were used. Bark is the standard spice and extract material, but other plant parts have traditional uses and different chemistry — so "cinnamon" on a label or in a quotation is not an identity.
Research and quality conversations both start from identity. NCCIH points out that cinnamon studies are difficult to interpret because it is often unclear which species or plant part was tested. Ingredient buying inherits the same logic: pricing, coumarin expectations, and label artwork all depend on which species actually went into the drum.
For a true cinnamon supplement, the species name belongs in the ingredient specification — Cinnamomum verum for Ceylon — with the plant part stated alongside it. Everything downstream inherits from that line.
Coumarin is the main reason the species question matters for daily-use supplements. The category-level picture from two public health bodies:
Cassia carries the higher coumarin load. BfR states that coumarin is contained in relatively high concentrations in cinnamon varieties collectively known as cassia cinnamon, and recommends moderate consumption of cassia. NCCIH adds nuance: consuming cassia cinnamon doesn't usually include enough coumarin to cause significant problems, but some cassia products contain high levels, and prolonged use could be an issue for sensitive people, such as those with liver disease. BfR also notes that in especially sensitive persons, even comparatively small quantities of coumarin can cause liver damage, although the effect is usually reversible.
Ceylon is the low-coumarin category. BfR points consumers who frequently use larger amounts of cinnamon toward Ceylon, which contains low levels of coumarin; NCCIH notes that Ceylon may contain a trace amount.
Two buying rules follow from that picture:
1. Category background is not batch evidence. "Ceylon is the low-coumarin species" is a statement about categories. It does not tell you what a specific extract lot contains. Treat coumarin as a per-batch question: which test method, which limit, which result, on the certificate of analysis for the lot you are buying.
2. Trace does not mean zero, and higher does not automatically mean unsafe. A "coumarin-free" claim is not supported by the species name alone, while NCCIH describes typical cassia consumption as usually not reaching problematic coumarin levels. The defensible question is not "which species is bad" but "what does the documentation show for this ingredient, at this serving size, in this market?"
Jurisdiction matters too. In the EU, maximum coumarin levels have applied to cinnamon-containing foods since 2011, cinnamon sold as a spice has no limit values, and isolated coumarin must not be added to foods (BfR). In the US, cinnamon supplements fall under the dietary supplement CGMP framework discussed below. Set coumarin specifications per destination market rather than copying one market's numbers worldwide.
One evidence boundary is worth keeping in view when writing product copy: NCCIH's bottom line is that research doesn't clearly support using cinnamon for any health condition, partly because studies often fail to define the species or plant part tested. The Ceylon-versus-cassia comparison is an identity and documentation story — not a health-claim story.
If you are benchmarking finished products while reading this, the published Ceylon cinnamon extract softgel specifications show how MINGYAN presents formula-level details (extract ratio, carrier oil, serving, count) — while batch-level results remain a certificate-of-analysis conversation.
Species, plant part, material form, coumarin, traceability — the five rows below turn "Ceylon vs. cassia" into a specification check you can run on any quotation.
Comparison point | Ceylon cinnamon | Cassia cinnamon | What to verify with your supplier |
Botanical species | Cinnamomum verum (syn. C. zeylanicum) | Cinnamomum aromaticum (syn. C. cassia) | Species name written into the ingredient specification, not just the marketing name |
Plant part | Bark — the standard spice and extract material | Bark | Plant part declared; other Cinnamomum parts differ chemically |
Raw material form | Thin, brittle quills with multiple soft layers | Thick, hard quills, usually a single curled layer | Appearance can suggest species in whole quills but cannot confirm powders or extracts — request documentary proof |
Coumarin background | Low levels at category level; NCCIH: may contain a trace amount | Relatively high concentrations at category level; some products high | Batch result and test method on the per-batch CoA; serving size and destination-market limits define the pass line |
Traceability documents | Same expectations as any botanical dietary ingredient | Same | Identity test per lot, CoA with methods, limits and results, supplier qualification, batch records, retained samples |
If your product is manufactured for the US market, FDA's dietary supplement CGMP rule (21 CFR Part 111) defines much of what "good documentation" looks like. According to FDA's Small Entity Compliance Guide:
l Each dietary ingredient requires at least one appropriate test or examination to verify identity, unless a petition-based exemption applies (21 CFR 111.75(a)(1)).
l Other component specifications may rely on a supplier's certificate of analysis — but only after the supplier is qualified by confirming the reliability of its test results; the CoA must describe the test methods, limits, and results, and reliance must be periodically reconfirmed (21 CFR 111.75(a)(2)).
l Tests and examinations must use scientifically valid methods; macroscopic analysis, microscopic analysis, and chemical analysis are among the acceptable approaches (21 CFR 111.75(h)).
l A subset of finished batches, identified through a sound statistical sampling plan, must be verified against product specifications (21 CFR 111.75(c)).
l Master manufacturing records and batch production records must be established and followed (21 CFR 111.210, 111.260), and reserve samples must be retained (21 CFR 111.83).
The guide itself describes FDA's current thinking and is formally a set of recommendations; the rule in 21 CFR Part 111 is the binding text. For a buyer, the practical translation is a document request list:
1. An ingredient specification naming the species, plant part, and extract details
2. A per-batch CoA showing the identity test method and result — plus the coumarin method and result where coumarin is a stated concern
3. The supplier-qualification approach where CoA reliance replaces in-house testing
4. Access to batch documentation (master and batch records) and the reserve-sample policy
5. Confirmation of which destination-market framework the specification is written against (US CGMP, EU food and supplement rules, or others)
It is also worth remembering, per NCCIH, that dietary supplements are not approved by the FDA before they are marketed — manufacturers and distributors are responsible for evaluating safety and labeling before selling. That responsibility is exactly why the document list above belongs in your supplier conversations rather than in trust-building copy alone.
The comparison becomes reusable when it is written into an internal brief before quotations start. A workable one-page brief fixes:
Ingredient identity: species (Cinnamomum verum), plant part (bark), extract form and ratio, and the carrier system
Serving architecture: serving size, herbal-equivalent versus actual extract weight, count per pack, and packaging format
Evidence plan: which parameters get batch-level verification (identity; coumarin, if it will be a stated concern), and which documents arrive with each lot
Market fit: destination market, applicable framework, and the label statements planned for that market
MINGYAN's published Ceylon cinnamon extract softgel (specification linked in the previous section) illustrates the format: a 12:1 extract ratio, MCT oil as the carrier, a stated 7,200 mg herbal equivalent per serving, and 120 softgels per resealable pouch, with formula, shell, count, and packaging available for customization under private label, OEM, and ODM arrangements. Two reading notes come from the published specification itself: the 7,200 mg figure is the herbal equivalent — distinct from the actual extract weight — and the 12:1 ratio is a concentration parameter for formulation. Neither figure is a measure of biological effect. Published specifications are a starting point for discussion; batch certificates and destination-market compliance remain the verification step.
If Ceylon cinnamon is on your development list, three inputs make the first supplier conversation concrete:
Market and format: destination market, dosage form, serving size, and target count or packaging
Documentation baseline: the specification and CoA expectations from the previous section, including whether coumarin will be a stated specification
Customization scope: extract concentration, shell material, softgel size and appearance, count, and packaging design — available options depend on formula compatibility, production requirements, and the intended sales market
You can bring the three inputs above to MINGYAN's team and discuss your custom supplement project, or go straight to the request:
Request the current ingredient specification for your Ceylon cinnamon project.
Q1: Is Ceylon cinnamon the same as cassia?
No. Both are dried bark from trees in the Cinnamomum genus, but they are different species. Ceylon cinnamon is Cinnamomum verum (also called Cinnamomum zeylanicum), known as "true cinnamon," and grows primarily in Sri Lanka. Cassia cinnamon is Cinnamomum aromaticum (also called Cinnamomum cassia), grown in southeastern Asia, and it is the most common type sold in North America. Because retail labels often say only "cinnamon," the species cannot be confirmed from a product name alone — it needs to be stated in the ingredient specification and confirmed through identity testing.
Q2: Does Ceylon cinnamon contain coumarin?
Usually only trace amounts. NCCIH notes that Ceylon cinnamon may contain a trace amount of coumarin, while coumarin is found in cassia cinnamon, and BfR describes cassia-type cinnamon as carrying relatively high concentrations with Ceylon containing low levels. Two points matter for supplement buyers: "low" does not mean "zero," so a low-coumarin position should be backed by batch data rather than the species name; and a category background is not a batch result — the per-batch certificate of analysis is the evidence.
Q3: How can buyers verify the cinnamon species?
Three checkpoints. First, documentation: the botanical name (Cinnamomum verum versus Cinnamomum aromaticum / C. cassia) and the plant part should be stated in the ingredient specification. Second, analysis: identity testing on the received ingredient — FDA's dietary supplement CGMP framework expects at least one appropriate test or examination to verify the identity of each dietary ingredient, using scientifically valid methods, which can include macroscopic, microscopic, or chemical examination. Third, consistency: species, plant part, and origin should match across the specification, the label artwork, and the batch documents. Appearance helps with whole quills but cannot confirm species in powders or extracts.
Q4: What documents should a supplier provide?
At minimum: an ingredient specification naming species, plant part, and extract details; a per-batch CoA that includes the test methods used, the limits applied, and the actual results; and, where the manufacturer relies on the CoA instead of testing, evidence that the supplier has been qualified and periodically reconfirmed. Under FDA's CGMP framework for US-market supplements, manufacturers also maintain master manufacturing records and batch production records, and retain reserve samples. For cinnamon specifically, ask whether coumarin has been tested and by which method, and how origin and traceability are documented — these are the points most often missing from a first quotation.
Q5: Does a 12:1 extract ratio mean the product is 12 times stronger?
No. A 12:1 ratio describes how much raw cinnamon was concentrated into the extract; a stated 7,200 mg herbal equivalent per serving refers back to the raw herb, not to the actual extract weight in the softgel. The published MINGYAN specification explicitly asks buyers to keep those two figures distinct when preparing the product specification and label. The ratio is a concentration parameter for formulation and costing — not a measure of biological effect — and product claims should follow the approved specification and destination-market requirements.
